Fig. 2From: Rheumatoid arthritis patients initiating rituximab with low number of previous bDMARDs failures may effectively reduce rituximab dose and experience fewer serious adverse events than patients on full dose: a 5-year cohort studySurvival plot of flare probability within the low dose groupBack to article page